In line with its focus on digital growth, Tech Mahindra has acquired 70 percent equity stake in Perigord Asset Holdings Limited, a digital workflow and artwork, labelling and BPO services firm. This acquisition will help strengthen Tech Mahindra’s position as a leading digital transformation enabler in the artwork and packaging services space with an integrated platform and services portfolio. It will also augment expertise in the global pharmaceutical and healthcare and life science (HLS) sectors.

The acquisition underlines the organisation’s focus on digital growth, under the NXT.NOW framework, which focuses on leveraging next generation technologies and delivering disruptive solutions to enable digital transformation and meet dynamic customer needs. It is also a part of Tech Mahindra’s long-term growth plan to build a presence across key markets in Ireland, Germany, USA, and India with enhanced global delivery.

“HLS is a key vertical for Tech Mahindra and this acquisition will expand our footprint globally in these domains. Perigord’s disruptive proprietary platform and expertise in the artwork space and life sciences industry will add significant value to our offerings and capabilities,” said Vivek Agarwal, President – BFSI, HLS and Corporate Development, Tech Mahindra.

Tech Mahindra will leverage Perigord’s offerings to deliver efficiency and automation levers across sectors, including consumer-packaged goods, medical devices and over the counter (OTC) products to enable growth and scalability in the future. With leading capabilities in the BPS (Business Process Services) segment and the SaaS (Software as a Service) implementation and roll-out, the acquisition will further establish the organisation as a preferred service provider in the Life Sciences industry across the digital supply chain.

Ritesh Idnani, President, Business Process Services, Tech Mahindra, said, “This acquisition lies at the centre of our strategic priorities around platform-led BPaaS (Business Process as a Service) offerings to expand our global footprint and bolster our capabilities in the digital supply chain in the healthcare and life sciences market.”